Advances in Development of Selective Antitumor Inhibitors That Target PARP-1
F Liu, J Chen, X Li, R Liu, Y Zhang… - Journal of Medicinal …, 2023 - ACS Publications
Cancer is a major threat to the lives and health of people around the world, and the
development of effective antitumor drugs that exhibit fewer toxic effects is an important …
development of effective antitumor drugs that exhibit fewer toxic effects is an important …
Immunotherapeutic approaches in ovarian cancer
H Yoon, A Kim, H Jang - Current Issues in Molecular Biology, 2023 - mdpi.com
Ovarian cancer (OC) is gynecological cancer, and diagnosis and treatment are continuously
advancing. Next-generation sequencing (NGS)-based diagnoses have emerged as novel …
advancing. Next-generation sequencing (NGS)-based diagnoses have emerged as novel …
Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor
Aims The overexpression of ABC transporters on cancer cell membranes is one of the most
common causes of multidrug resistance (MDR). This study investigates the impact of ABCC1 …
common causes of multidrug resistance (MDR). This study investigates the impact of ABCC1 …
Pentagalloyl glucose: a review of anticancer properties, molecular targets, mechanisms of action, pharmacokinetics, and safety profile
C Wen, N Dechsupa, Z Yu, X Zhang, S Liang, X Lei… - Molecules, 2023 - mdpi.com
Pentagalloyl glucose (PGG) is a natural hydrolyzable gallotannin abundant in various plants
and herbs. It has a broad range of biological activities, specifically anticancer activities, and …
and herbs. It has a broad range of biological activities, specifically anticancer activities, and …
PARP inhibitors combined with radiotherapy: are we ready?
C Sun, A Chu, R Song, S Liu, T Chai… - Frontiers in …, 2023 - frontiersin.org
PARP was an enzyme found in the nucleus of eukaryotic cells that played a crucial role in
repairing damaged DNA. Recently, PARP inhibitors have demonstrated great potential in …
repairing damaged DNA. Recently, PARP inhibitors have demonstrated great potential in …
Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
M Rana, A Thakur, C Kaur, CH Pan… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction PARP inhibitors block the DNA-repairing mechanism of PARP and represent a
promising class of anti-cancer therapy. The last decade has witnessed FDA approvals of …
promising class of anti-cancer therapy. The last decade has witnessed FDA approvals of …
PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer
K Chen, M Dai, Q Luo, Y Wang, W Shen, Y Liao… - … International Journal of …, 2023 - Elsevier
The PARP1 protein plays a key role in DNA damage repair and ADP-ribosylation to regulate
gene expression. Strategies to target PARP1 have rapidly been developed for cancer …
gene expression. Strategies to target PARP1 have rapidly been developed for cancer …
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity …
Abstract Poly (ADP-ribose) polymerase (PARP) is considered an essential component in
case of DNA (Deoxyribonucleic acid) damage, response by sensing DNA damage and …
case of DNA (Deoxyribonucleic acid) damage, response by sensing DNA damage and …
Tau Aggregation‐Dependent Lipid Peroxide Accumulation Driven by the hsa_circ_0001546/14‐3‐3/CAMK2D/Tau Complex Inhibits Epithelial Ovarian Cancer …
BS Chai, Y Wu, HH Yang, BF Fan, SY Cao… - Advanced …, 2024 - Wiley Online Library
Intraperitoneal dissemination is the main method of epithelial ovarian cancer (EOC)
metastasis, which is related to poor prognosis and a high recurrence rate. Circular RNAs …
metastasis, which is related to poor prognosis and a high recurrence rate. Circular RNAs …
Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity
S He, A Wang, J Wang, Z Tang, X Wang… - Journal of Cancer …, 2024 - Springer
Purpose Cervical cancer is a common gynecological malignancy, pathologically associated
with persistent infection of high-risk types of human papillomavirus (HPV). Previous studies …
with persistent infection of high-risk types of human papillomavirus (HPV). Previous studies …